Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | LMND | CDNA |
|---|---|---|
| Price | $46.67 | $69.85 |
| Change today | ▲ 0.39% | ▲ 4.02% |
| Market cap | $3.61B | $3.61B |
| Return, 3 months | – | +146.7% |
| Return, year to date | – | +270.8% |
| Return, 1 year | – | +366.9% |
| P/E (TTM) | -25.6 | 33.6 |
| P/B | 7.2 | 8.5 |
| P/E percentile vs own 5y | – | 100th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +13.8% |
| Net profit growth (YoY) | – | -140.6% |
| Gross margin | – | 67.6% |
| Operating margin | – | -6.6% |
| Net margin | – | -5.6% |
| Return on equity | – | -6.3% |
| Analyst target vs. price | +10.7% | -10.9% |
| Analyst buy share | 20% | 60% |
| RSI (14) | – | 84 |
| 30-day volatility | – | 50.7% |
| Max drawdown, 1 year | – | -23.6% |
| Trend read | – | Strong uptrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
